Page last updated: 2024-10-23

bepridil and Colorectal Cancer

bepridil has been researched along with Colorectal Cancer in 2 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Research Excerpts

ExcerptRelevanceReference
"To achieve an adequate plasma concentration of bepridil, a calcium channel blocker, which reverts multidrug resistance (MDR) in vitro, when administered in combination with vinblastine in patients with advanced colorectal cancer, a tumor characterized by high MDR1 gene expression."5.07Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil. ( Giaccone, G; Kuiper, CM; Linn, SC; Pinedo, HM; van der Valk, P; van Groeningen, CJ; van Kalken, CK; van Tellingen, O, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Linn, SC2
van Kalken, CK1
van Tellingen, O1
van der Valk, P1
van Groeningen, CJ1
Kuiper, CM1
Pinedo, HM2
Giaccone, G2

Trials

1 trial available for bepridil and Colorectal Cancer

ArticleYear
Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfa

1994

Other Studies

1 other study available for bepridil and Colorectal Cancer

ArticleYear
Complete remission of metastatic colorectal cancer: a pitfall in a multidrug resistance reversal trial.
    Lancet (London, England), 1994, Jun-25, Volume: 343, Issue:8913

    Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Bepridil; Clinical Trials as Topic; Colorectal Neoplas

1994